Clinical Trials

10 enrolled

Stomach Neoplasms, Colorectal Neoplasms

NCT06225622 2024-03-19

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

78 enrolled

Colorectal Neoplasms

NCT02102789 2024-03-04

A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis

142 enrolled

Colorectal Neoplasms

NCT04338191 2023-12-27

FANTASTIC

638 enrolled

Colorectal Neoplasms

NCT05839470 2023-11-15

Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer

20 enrolled

Colorectal Neoplasms

NCT04034459 2023-11-14

AIO-KRK-0116

109 enrolled

Colorectal Neoplasms

NCT04310176 2023-11-13

REVOLUTION

200 enrolled

Colorectal Neoplasms

NCT05081687 2023-10-11

BRAZIL-TNT

150 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT06003998 2023-08-22

INTERACT-II

85 enrolled

Colorectal Neoplasms

NCT05832398 2023-06-28

Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer

Phase NA Unknown

186 enrolled

Colorectal Neoplasms

NCT03391934 2023-04-05

Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer

234 enrolled

Colorectal Neoplasms

NCT01628211 2023-03-24

HIPEC

140 enrolled

Colorectal Neoplasms

NCT05480280 2023-02-28

FIND

18 enrolled

Phase EARLY_PHASE1 Unknown

Colorectal Neoplasms

NCT05590117 2022-10-21

Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer

48 enrolled

GastrointestinalOther

Colonic Neoplasms, Neuritis, Colorectal Neoplasms, Mucositis

NCT05200299 2022-01-20

mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer

Colorectal Neoplasms

NCT03487939 2021-04-19

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

30 enrolled

Colorectal Neoplasms

NCT02135887 2020-12-22

MB-6

Unknown

184 enrolled

Neutropenia, Colorectal Neoplasms

NCT04668976 2020-12-21

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Colorectal Neoplasms, Cholangiocarcinoma

NCT02339116 2020-02-05

TRIBE2

654 enrolled

Colorectal Neoplasms

NCT04097444 2019-10-31

QUATTRO-II

112 enrolled

Colorectal Neoplasms

NCT01802645 2019-09-11

CELIM2

91 enrolled

Colorectal Neoplasms

NCT02087475 2019-06-05

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

360 enrolled

Neoplasm Metastasis, Neoplasm Recurrence, Local, Colorectal Neoplasms

NCT00647530 2019-05-17

FOxTROT

Phase 2/3 Unknown

1,053 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT03880877 2019-03-21

Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer

153 enrolled

Colorectal Neoplasms

NCT03711240 2019-03-13

CBL

40 enrolled

Colorectal Neoplasms

NCT02624726 2019-02-22

MINOAS

31 enrolled

Colorectal Neoplasms

NCT01271582 2019-01-29

Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients

Phase 4 Unknown

1,500 enrolled

Neutropenia, Stomach Neoplasms, Colorectal Neoplasms

NCT03303495 2017-10-06

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

280 enrolled

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT01308086 2017-08-09

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

2,000 enrolled

Neoplasms, Colorectal Neoplasms

NCT02870036 2017-07-14

Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors

243 enrolled

Colorectal Neoplasms

NCT01895257 2017-07-07

Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer

162 enrolled

Colorectal Neoplasms

NCT03210064 2017-07-06

Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients

42 enrolled

Colorectal Neoplasms

NCT02935764 2016-10-17

FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

164 enrolled

Colorectal Neoplasms

NCT02476045 2016-09-14

Valentino

224 enrolled

Colorectal Neoplasms

NCT02785146 2016-06-08

Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer

230 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT02453464 2016-04-20

A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer

36 enrolled

Colorectal Neoplasms

NCT00058474 2016-03-23

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

1,608 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT02515734 2015-08-05

DEEPER

360 enrolled

Colorectal Neoplasms

NCT02415699 2015-04-14

DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer

Phase 2/3 Unknown

Colorectal Neoplasms

NCT02376452 2015-03-03

Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

Colorectal Neoplasms

NCT02128425 2014-05-07

FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer

162 enrolled

Colorectal Neoplasms

NCT00433927 2014-03-14

5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

568 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00008281 2014-01-06

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00027833 2014-01-06

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00002692 2013-12-19

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

312 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00002893 2013-12-19

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

900 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00021281 2013-12-19

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00408551 2013-12-19

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

20 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT01972503 2013-12-11

Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer

Phase 4 Unknown

300 enrolled

Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT01529164 2013-11-27

Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer

51 enrolled